$NSP
INSPERITY, INC. Stock $nsp

$nsp Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000100075320000025 Filed on May 05, 2020

Income Statement

Concept	2020 Q1	2019 Q1	2018 Q3
Revenue	$1.229B	$1.153B	$925.1M
YoY Change	6.63%	13.67%	16.29%
Cost Of Revenue	$995.5M	$926.3M	$759.1M
YoY Change	7.47%	13.7%	15.8%
Gross Profit	$234.0M	$226.7M	$166.1M
YoY Change	3.22%	13.52%	18.64%
Gross Profit Margin	19.03%	19.66%	17.95%
Selling, General & Admin	$141.2M	$134.6M	$112.3M
YoY Change	4.9%	3.7%	6.45%
% of Gross Profit	60.34%	59.37%	67.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.600M	$6.700M	$5.600M
YoY Change	13.43%	28.85%	19.15%
% of Gross Profit	3.25%	2.96%	3.37%
Operating Expenses	$148.8M	$141.3M	$117.9M
YoY Change	5.34%	4.62%	7.04%
Operating Profit	$85.22M	$85.46M	$48.13M
YoY Change	-0.28%	32.08%	61.53%
Interest Expense	$2.362M	$1.681M	$1.174M
YoY Change	40.51%	57.1%	31.32%
% of Operating Profit	2.77%	1.97%	2.44%
Other Income/Expense, Net
YoY Change
Pretax Income	$84.74M	$87.03M	$48.99M
YoY Change	-2.63%	33.7%	63.73%
Income Tax	$22.65M	$10.74M	$12.78M
% Of Pretax Income	26.72%	12.34%	26.09%
Net Earnings	$62.09M	$76.29M	$36.21M
YoY Change	-18.61%	52.61%	88.56%
Net Earnings / Revenue	5.05%	6.62%	3.91%
Basic Earnings Per Share	$1.59	$1.86	$0.86
Diluted Earnings Per Share	$1.58	$1.85	$0.86
COMMON SHARES
Basic Shares Outstanding	38.80M shares	40.51M shares	41.33M shares
Diluted Shares Outstanding	39.07M shares	40.65M shares	41.55M shares

Balance Sheet

Concept	2020 Q1	2019 Q1	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$424.2M	$452.5M	$365.9M
YoY Change	-6.25%	26.89%	27.09%
Cash & Equivalents	$404.7M	$398.9M	$398.9M
Short-Term Investments	$19.50M	$53.60M	$37.60M
Other Short-Term Assets	$40.43M	$36.62M	$24.27M
YoY Change	10.4%	29.0%	26.03%
Inventory
Prepaid Expenses
Receivables	$520.7M	$421.3M	$3.402M
Other Receivables	$0.00	$0.00	$4.500M
Total Short-Term Assets	$1.079B	$980.1M	$846.2M
YoY Change	10.12%	22.36%	26.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$160.3M	$116.1M	$100.7M
YoY Change	38.03%	19.65%	7.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.010M	$5.534M	$5.663M
YoY Change	8.6%	0.38%	26.29%
Total Long-Term Assets	$443.1M	$370.9M	$290.5M
YoY Change	19.47%	27.7%	5.13%
TOTAL ASSETS
Total Short-Term Assets	$1.079B	$980.1M	$846.2M
Total Long-Term Assets	$443.1M	$370.9M	$290.5M
Total Assets	$1.522B	$1.351B	$1.137B
YoY Change	12.69%	23.78%	19.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.240M	$7.854M	$5.316M
YoY Change	-20.55%	42.36%	73.16%
Accrued Expenses	$51.73M	$49.24M	$24.60M
YoY Change	5.05%	77.8%	17.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$888.5M	$850.4M	$697.3M
YoY Change	4.48%	19.84%	20.35%
LONG-TERM LIABILITIES
Long-Term Debt	$369.4M	$144.4M	$104.4M
YoY Change	155.82%	38.31%	0.0%
Other Long-Term Liabilities	$259.3M	$0.00	$183.1M
YoY Change		-100.0%	13.23%
Total Long-Term Liabilities	$637.3M	$381.4M	$287.5M
YoY Change	67.09%	36.7%	8.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$888.5M	$850.4M	$697.3M
Total Long-Term Liabilities	$637.3M	$381.4M	$287.5M
Total Liabilities	$1.526B	$1.232B	$984.8M
YoY Change	23.86%	24.59%	16.48%
SHAREHOLDERS EQUITY
Retained Earnings	$545.3M	$460.9M	$381.5M
YoY Change	18.31%	36.55%	15.9%
Common Stock	$46.88M	$34.39M	$32.60M
YoY Change	36.33%	48.2%	57.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$595.5M	$376.1M	$262.2M
YoY Change	58.33%	45.83%	5.74%
Treasury Stock Shares
Shareholders Equity	-$3.310M	$119.2M	$151.9M
YoY Change
Total Liabilities & Shareholders Equity	$1.522B	$1.351B	$1.137B
YoY Change	12.69%	23.78%	19.98%

Cashflow Statement

Concept	2020 Q1	2019 Q1	2018 Q3
OPERATING ACTIVITIES
Net Income	$62.09M	$76.29M	$36.21M
YoY Change	-18.61%	52.61%	88.56%
Depreciation, Depletion And Amortization	$7.600M	$6.700M	$5.600M
YoY Change	13.43%	28.85%	19.15%
Cash From Operating Activities	$23.79M	$117.7M	$53.00M
YoY Change	-79.79%	289.8%	25.0%
INVESTING ACTIVITIES
Capital Expenditures	$15.63M	$5.608M	-$7.500M
YoY Change	178.62%	-14.84%	31.58%
Acquisitions
YoY Change
Other Investing Activities	$15.30M	$7.300M	-$30.50M
YoY Change	109.59%		30400.0%
Cash From Investing Activities	-$314.0K	$1.713M	-$38.00M
YoY Change	-118.33%	-126.07%	555.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$25.60M	-$40.34M	-7.900M
YoY Change	-163.47%	-342.77%	5.33%
NET CHANGE
Cash From Operating Activities	$23.79M	$117.7M	53.00M
Cash From Investing Activities	-$314.0K	$1.713M	-38.00M
Cash From Financing Activities	$25.60M	-$40.34M	-7.900M
Net Change In Cash	$49.08M	$79.07M	7.100M
YoY Change	-37.94%	96.51%	-75.6%
FREE CASH FLOW
Cash From Operating Activities	$23.79M	$117.7M	$53.00M
Capital Expenditures	$15.63M	$5.608M	-$7.500M
Free Cash Flow	$8.162M	$112.1M	$60.50M
YoY Change	-92.72%	374.77%	25.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001000753
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	INSPERITY, INC.
CY2020Q1	nsp	Prepaid Health Insurance Noncurrent PrepaidHealthInsuranceNoncurrent	9000000	USD
CY2020Q1	nsp	Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Long Term Liabilities TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInLongTermLiabilities	Greater than 1 year
CY2020Q1	nsp	Time Period Incurred Claims Expected To Be Paid Included In Deposits TimePeriodIncurredClaimsExpectedToBePaidIncludedInDeposits	Greater than 1 year
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	1-13998
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	76-0479645
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	19001 Crescent Springs Drive
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Kingwood,
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77339
CY2020Q1	dei	City Area Code CityAreaCode	281
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	358-8986
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock, $.01 par value per share
CY2020Q1	dei	Trading Symbol TradingSymbol	NSP
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38766043	shares
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	404728000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	367342000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	48349000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	49295000	USD
CY2020Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	19508000	USD
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	34728000	USD
CY2020Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	520745000	USD
CY2019Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	465779000	USD
CY2020Q1	us-gaap	Prepaid Insurance PrepaidInsurance	45525000	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	10418000	USD
CY2020Q1	us-gaap	Other Assets Current OtherAssetsCurrent	40425000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	43493000	USD
CY2020Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3691000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	1079280000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	974746000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	160297000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	147706000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	58461000	USD
CY2019Q4	nsp	Prepaid Health Insurance Noncurrent PrepaidHealthInsuranceNoncurrent	9000000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56886000	USD
CY2020Q1	nsp	Deposits Health Insurance DepositsHealthInsurance	8100000	USD
CY2019Q4	nsp	Deposits Health Insurance DepositsHealthInsurance	8100000	USD
CY2020Q1	nsp	Deposits Workers Compensation DepositsWorkersCompensation	188549000	USD
CY2019Q4	nsp	Deposits Workers Compensation DepositsWorkersCompensation	175913000	USD
CY2020Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	12711000	USD
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	12714000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	3956000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6010000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5975000	USD
CY2020Q1	us-gaap	Assets Assets	1522408000	USD
CY2019Q4	us-gaap	Assets Assets	1394996000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	6240000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4565000	USD
CY2020Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	268245000	USD
CY2019Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	277248000	USD
CY2020Q1	nsp	Accrued Worksite Employee Payroll Costs AccruedWorksiteEmployeePayrollCosts	436764000	USD
CY2019Q4	nsp	Accrued Worksite Employee Payroll Costs AccruedWorksiteEmployeePayrollCosts	401859000	USD
CY2020Q1	nsp	Accrued Health Insurance Costs AccruedHealthInsuranceCosts	46841000	USD
CY2019Q4	nsp	Accrued Health Insurance Costs AccruedHealthInsuranceCosts	21180000	USD
CY2020Q1	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	52311000	USD
CY2019Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	52868000	USD
CY2020Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	21610000	USD
CY2019Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	52612000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51729000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	58713000	USD
CY2020Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	4718000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	888458000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	869045000	USD
CY2020Q1	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	197633000	USD
CY2019Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	193609000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	369400000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	269400000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61623000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	58863000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	8604000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2020Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	637260000	USD
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	521872000	USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	555000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	555000	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	46327000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	48141000	USD
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	595487000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	544102000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	545295000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	499485000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-3310000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4079000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1522408000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1394996000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1229483000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1153010000	USD
CY2020Q1	nsp	Payroll Taxes Benefits And Workers Compensation Costs PayrollTaxesBenefitsAndWorkersCompensationCosts	995461000	USD
CY2019Q1	nsp	Payroll Taxes Benefits And Workers Compensation Costs PayrollTaxesBenefitsAndWorkersCompensationCosts	926293000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	234022000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	226717000	USD
CY2020Q1	nsp	Salaries Wages And Payroll Taxes SalariesWagesAndPayrollTaxes	86501000	USD
CY2019Q1	nsp	Salaries Wages And Payroll Taxes SalariesWagesAndPayrollTaxes	83380000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6552000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6040000	USD
CY2020Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	8460000	USD
CY2019Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	6952000	USD
CY2020Q1	us-gaap	Advertising Expense AdvertisingExpense	4833000	USD
CY2019Q1	us-gaap	Advertising Expense AdvertisingExpense	5031000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34853000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33162000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7602000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6691000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	148801000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	141256000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	85221000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	85461000	USD
CY2020Q1	us-gaap	Interest Income Other InterestIncomeOther	1879000	USD
CY2019Q1	us-gaap	Interest Income Other InterestIncomeOther	3245000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	2362000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	1681000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	84738000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	87025000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22646000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20674000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	35107000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	16517000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-3068000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10736000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	62092000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	76289000	USD
CY2020Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	462000	USD
CY2019Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	1031000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	61630000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	75258000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.59
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.86
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.58
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.85
CY2020Q1	nsp	Gross Billings GrossBillings	7436754000	USD
CY2019Q1	nsp	Gross Billings GrossBillings	6871670000	USD
CY2020Q1	nsp	Worksite Employee Payroll Cost WorksiteEmployeePayrollCost	6207271000	USD
CY2019Q1	nsp	Worksite Employee Payroll Cost WorksiteEmployeePayrollCost	5718660000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1229483000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1153010000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	62092000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	76289000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7602000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6691000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6552000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6040000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12560000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8671000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	54966000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	8893000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3403000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	809000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1675000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2768000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-9003000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	46896000	USD
CY2020Q1	nsp	Increase Decreasein Wse Epayrollexpense IncreaseDecreaseinWSEEpayrollexpense	34905000	USD
CY2019Q1	nsp	Increase Decreasein Wse Epayrollexpense IncreaseDecreaseinWSEEpayrollexpense	33883000	USD
CY2020Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	25661000	USD
CY2020Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2363000	USD
CY2019Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	10679000	USD
CY2020Q1	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	3467000	USD
CY2019Q1	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	1367000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-46531000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-23656000	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	8409000	USD
CY2019Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	498000	USD
CY2020Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-38305000	USD
CY2019Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	41408000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23787000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	117697000	USD
CY2020Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8689000	USD
CY2019Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	35538000	USD
CY2020Q1	nsp	Marketable Securities Proceeds From Dispositions MarketableSecuritiesProceedsFromDispositions	0	USD
CY2019Q1	nsp	Marketable Securities Proceeds From Dispositions MarketableSecuritiesProceedsFromDispositions	5499000	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	24000000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	37360000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15625000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5608000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-314000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1713000	USD
CY2020Q1	nsp	Treasury Stock Acquired TreasuryStockAcquired	61203000	USD
CY2019Q1	nsp	Treasury Stock Acquired TreasuryStockAcquired	29037000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	15557000	USD
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	12386000	USD
CY2020Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	100000000	USD
CY2019Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2019Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1085000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25603000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40338000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	49076000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	79072000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	592550000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	535474000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	641626000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	614546000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	367342000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	326773000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	49295000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	42227000	USD
CY2019Q4	nsp	Deposits Workers Compensation DepositsWorkersCompensation	175913000	USD
CY2018Q4	nsp	Deposits Workers Compensation DepositsWorkersCompensation	166474000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	592550000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	535474000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	404728000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	398936000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	48349000	USD
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	44705000	USD
CY2020Q1	nsp	Deposits Workers Compensation DepositsWorkersCompensation	188549000	USD
CY2018Q3	nsp	Deposits Workers Compensation DepositsWorkersCompensation	170905000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	641626000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	614546000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6787000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3140000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	4079000	USD
CY2020Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	-61203000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6552000	USD
CY2020Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-642000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	-15557000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	85000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	62092000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-3310000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	77676000	USD
CY2019Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	-29037000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6040000	USD
CY2019Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-599000	USD
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	-12386000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	13000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	76289000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	119194000	USD
CY2020Q1	nsp	Percentageofourhealthinsurancecoverageprovidedby United PercentageofourhealthinsurancecoverageprovidedbyUnited	0.87
CY2020Q1	nsp	Number Of Days In Advance Of Beginning Of Reporting Quarter Carrier Establishes Cash Funding Rates NumberOfDaysInAdvanceOfBeginningOfReportingQuarterCarrierEstablishesCashFundingRates	P90D
CY2020Q1	nsp	Prepaid Health Insurance Noncurrent PrepaidHealthInsuranceNoncurrent	9000000.0	USD
CY2020Q1	nsp	Required Deposit For Health Care Costs RequiredDepositForHealthCareCosts	6500000	USD
CY2019Q4	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1500000	USD
CY2020Q1	nsp	Decrease Increase In Accrued Workers Compensation Costs For Changes In Estimated Losses DecreaseIncreaseInAccruedWorkersCompensationCostsForChangesInEstimatedLosses	10100000	USD
CY2020Q1	nsp	Prepaid Health Insurance Current And Noncurrent PrepaidHealthInsuranceCurrentAndNoncurrent	36800000	USD
CY2020Q1	nsp	Prepaid Health Insurance Noncurrent PrepaidHealthInsuranceNoncurrent	9000000.0	USD
CY2020Q1	nsp	Prepaid Health Insurance Current PrepaidHealthInsuranceCurrent	27800000	USD
CY2020Q1	nsp	Premiums Owed To United PremiumsOwedToUnited	40700000	USD
CY2020Q1	nsp	Benefits Costs Incurred Reduced Relatedto Runoff BenefitsCostsIncurredReducedRelatedtoRunoff	-1500000	USD
CY2019Q1	nsp	Benefits Costs Incurred Reduced Relatedto Runoff BenefitsCostsIncurredReducedRelatedtoRunoff	-300000	USD
CY2020Q1	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1000000	USD
CY2020Q1	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1000000	USD
CY2020Q1	nsp	Workers Compensation Maximum Aggregate Economic Burden For Claims In Excess Of First Layer Cap Per Policy Year WorkersCompensationMaximumAggregateEconomicBurdenForClaimsInExcessOfFirstLayerCapPerPolicyYear	6000000	USD
CY2020Q1	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1000000	USD
CY2019Q4	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1500000	USD
CY2019Q4	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1500000	USD
CY2019Q4	nsp	Workers Compensation Maximum Aggregate Economic Burden For Claims In Excess Of First Layer Cap Per Policy Year WorkersCompensationMaximumAggregateEconomicBurdenForClaimsInExcessOfFirstLayerCapPerPolicyYear	6000000	USD
CY2019Q1	nsp	Decrease Increase In Accrued Workers Compensation Costs For Changes In Estimated Losses DecreaseIncreaseInAccruedWorkersCompensationCostsForChangesInEstimatedLosses	7800000	USD
CY2020Q1	nsp	Us Treasury Rates That Correspond With Weighted Average Estimated Claim Payout Period USTreasuryRatesThatCorrespondWithWeightedAverageEstimatedClaimPayoutPeriod	0.010
CY2019Q1	nsp	Us Treasury Rates That Correspond With Weighted Average Estimated Claim Payout Period USTreasuryRatesThatCorrespondWithWeightedAverageEstimatedClaimPayoutPeriod	0.025
CY2019Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	242904000	USD
CY2018Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	229639000	USD
CY2020Q1	nsp	Workers Compensation Expense WorkersCompensationExpense	14339000	USD
CY2019Q1	nsp	Workers Compensation Expense WorkersCompensationExpense	15787000	USD
CY2020Q1	nsp	Workers Compensation Discount Changed During Period WorkersCompensationDiscountChangedDuringPeriod	-200000	USD
CY2019Q1	nsp	Workers Compensation Discount Changed During Period WorkersCompensationDiscountChangedDuringPeriod	-1689000	USD
CY2020Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	-11121000	USD
CY2019Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	-12409000	USD
CY2020Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	245922000	USD
CY2019Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	231328000	USD
CY2020Q1	nsp	Workers Compensation Liability Net Of Admin Fees Current WorkersCompensationLiabilityNetOfAdminFeesCurrent	48289000	USD
CY2019Q1	nsp	Workers Compensation Liability Net Of Admin Fees Current WorkersCompensationLiabilityNetOfAdminFeesCurrent	44704000	USD
CY2020Q1	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	197633000	USD
CY2019Q1	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	186624000	USD
CY2020Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	245922000	USD
CY2019Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	231328000	USD
CY2020Q1	nsp	Workers Compensation Administrative Fees Accrued WorkersCompensationAdministrativeFeesAccrued	4000000.0	USD
CY2020Q1	nsp	Undiscounted Accrued Workers Compensation Costs UndiscountedAccruedWorkersCompensationCosts	265600000	USD
CY2019Q1	nsp	Undiscounted Accrued Workers Compensation Costs UndiscountedAccruedWorkersCompensationCosts	250200000	USD
CY2020Q1	nsp	Time Period Incurred Claims Expected To Be Paid Recorded As Restricted TimePeriodIncurredClaimsExpectedToBePaidRecordedAsRestricted	P1Y
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	48300000	USD
CY2020Q1	nsp	Deposits Workers Compensation DepositsWorkersCompensation	188500000	USD
CY2020Q1	nsp	Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Short Term Liabilities TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInShortTermLiabilities	P1Y
CY2020Q1	nsp	Unbilled Unbilled	509300000	USD
CY2019Q4	nsp	Unbilled Unbilled	448100000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1229483000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1153010000	USD
CY2020Q1	nsp	Money Market Funds Overnight Holdings At Carrying Value MoneyMarketFundsOvernightHoldingsAtCarryingValue	372469000	USD
CY2019Q4	nsp	Money Market Funds Overnight Holdings At Carrying Value MoneyMarketFundsOvernightHoldingsAtCarryingValue	349857000	USD
CY2020Q1	us-gaap	Short Term Investments ShortTermInvestments	39002000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	47946000	USD
CY2020Q1	us-gaap	Cash Cash	26266000	USD
CY2019Q4	us-gaap	Cash Cash	36521000	USD
CY2020Q1	us-gaap	Drafts Payable DraftsPayable	13501000	USD
CY2019Q4	us-gaap	Drafts Payable DraftsPayable	32254000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	424236000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	402070000	USD
CY2020Q1	nsp	Payroll Withholdings Included In Cash Balance PayrollWithholdingsIncludedInCashBalance	235200000	USD
CY2019Q4	nsp	Payroll Withholdings Included In Cash Balance PayrollWithholdingsIncludedInCashBalance	234600000	USD
CY2020Q1	nsp	Client Prepayments Included In Cash Balance ClientPrepaymentsIncludedInCashBalance	-22100000	USD
CY2019Q4	nsp	Client Prepayments Included In Cash Balance ClientPrepaymentsIncludedInCashBalance	-59600000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	387263000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	363075000	USD
CY2020Q1	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue	18060000	USD
CY2019Q4	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue	34728000	USD
CY2020Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	6148000	USD
CY2019Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	0	USD
CY2020Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	411471000	USD
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	397803000	USD
CY2020Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	19412000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	96000	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	0	USD
CY2020Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	19508000	USD
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	34716000	USD
CY2019	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	13000	USD
CY2019	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	1000	USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	34728000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	19412000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	19508000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	0	USD
CY2020Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	500000000	USD
CY2020Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	550000000	USD
CY2020Q1	nsp	Percentage Of Subsidiary Stock Securing Debt PercentageOfSubsidiaryStockSecuringDebt	0.65
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	369400000	USD
CY2020Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1000000.0	USD
CY2020Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	129600000	USD
CY2020Q1	nsp	Applicable Margin Federal Funds Rate ApplicableMarginFederalFundsRate	0.0050
CY2020Q1	nsp	Applicable Margin30 Day Libor ApplicableMargin30DayLibor	0.0200
CY2020Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0025
CY2020Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0329
CY2020Q1	nsp	Aggregatenumberofsharesrepurchasedduringtheperiod Aggregatenumberofsharesrepurchasedduringtheperiod	878305	shares
CY2020Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000	shares
CY2020Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	728000	shares
CY2020Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	685833	shares
CY2020Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	150305	shares
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2020Q1	us-gaap	Dividends Dividends	15600000	USD
CY2019Q1	us-gaap	Dividends Dividends	12400000	USD
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	142000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39068000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40650000	shares
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	146000000	USD
CY2020Q1	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	0	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	62092000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	76289000	USD
CY2020Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	462000	USD
CY2019Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	1031000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	61630000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	75258000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38802000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40508000	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	266000	shares

Files In Submission

Name	View Source	Status
0001000753-20-000025-index-headers.html	Edgar Link	pending
0001000753-20-000025-index.html	Edgar Link	pending
0001000753-20-000025.txt	Edgar Link	pending
0001000753-20-000025-xbrl.zip	Edgar Link	pending
a03312020-10qdocument.htm	Edgar Link	pending
a03312020-10qdocument_htm.xml	Edgar Link	completed
a03312020-nspex101.htm	Edgar Link	pending
a03312020-nspex311.htm	Edgar Link	pending
a03312020-nspex312.htm	Edgar Link	pending
a03312020-nspex321.htm	Edgar Link	pending
a03312020-nspex322.htm	Edgar Link	pending
chart-07ad4017d03f662550f.jpg	Edgar Link	pending
chart-4774077b73c4f71cdbc.jpg	Edgar Link	pending
chart-5456ac7dae82e00a9ac.jpg	Edgar Link	pending
chart-57b623cfd8e617a4792.jpg	Edgar Link	pending
chart-5ca99a65065d2d236e6.jpg	Edgar Link	pending
chart-687ad743e26098fa253.jpg	Edgar Link	pending
chart-856e757b20ea937beb6.jpg	Edgar Link	pending
chart-986ce9423599f33d02b.jpg	Edgar Link	pending
chart-b60d2af8c8a27e1e702.jpg	Edgar Link	pending
chart-cdae35d3e7a67dbfff7.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
insperitylogoa08.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nsp-20200331.xsd	Edgar Link	pending
nsp-20200331_cal.xml	Edgar Link	unprocessable
nsp-20200331_def.xml	Edgar Link	unprocessable
nsp-20200331_lab.xml	Edgar Link	unprocessable
nsp-20200331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uhclogo.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NSP
INSPERITY, INC. Stock $nsp

2020 Q1 Form 10-Q Financial Statement

#000100075320000025 Filed on May 05, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NSP INSPERITY, INC. Stock $nsp

2020 Q1 Form 10-Q Financial Statement

#000100075320000025 Filed on May 05, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NSP
INSPERITY, INC. Stock $nsp